Owkin
Sells K Pro, an AI scientist built from multiple agents, tools and skills that runs as autopilot or co-pilot across the drug development pipeline for pharma teams. The company says it learns from a patient data network covering 25 million patients across 840 hospitals.
Press release · 12 Mar 2026Press release · 13 Oct 2026Press release · 13 Oct 2026Products
Selected offerings — the AI products recorded here, not the vendor's full catalogue.
-
Research agent that answers biomedical questions across Owkin's clinical and molecular datasets and ranks therapeutic targets and gene candidates.
-
Multimodal AI-derived spatial biomarkers, developed with pharmaceutical partners to inform drug discovery and patient stratification.
Similar products 13
No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.
Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.
Sources
- Stage, from total funding
-
Company disclosure · 27 Aug 2026
"Owkin has raised $304.1m USD from investors..." — Owkin's own press-kit FAQ page, read 2026-08-27.
- Founded
-
Infobox: "Founded on August 3, 2016."
Something wrong here? Send a correction — quote this company id: owkin.